Literature DB >> 16837704

Q fever in the Southern California desert: epidemiology, clinical presentation and treatment.

Lawrence A Cone1, Noel Curry, Phillip Shaver, David Brooks, James DeForge, Barbara E Potts.   

Abstract

Despite the absence of a natural reservoir for Q fever in the desert of Southern California, six cases have been identified during the past 32 years. During that period of time, two areas have been used by northern sheep ranchers from Idaho and Wyoming to import sheep to an area in the Coachella Valley through 1985. Thereafter, because of housing development, the sheep area was moved to Blythe along the Colorado River. All but two of these patients probably acquired infection by Coxiella burnetii by living or working in close proximity to these grazing areas but not directly involved with the sheep. The shift of infected patients from the Coachella Valley to Blythe (100 miles distant) seems to support that supposition. All patients with acute Q fever developed antibodies primarily to phase II antigen, whereas the only person with chronic Q fever developed phase I antibodies. All patients presented with granulomatous hepatitis. One also had a pulmonary infiltrate, and the single individual with chronic Q fever also had a mitral valve prosthesis, although echocardiography could not define endocarditis. All patients with acute infections responded to 3-5 weeks of therapy with doxycycline, whereas the patient with chronic disease failed 3 years of therapy with combination regimens. Further studies at the Eisenhower Medical Center on the prevalence of infection in Blythe, CA, and elsewhere are anticipated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837704     DOI: 10.4269/ajtmh.2006.75.1.0750029

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

2.  A Case of Acute Q Fever Hepatitis Diagnosed by F-18 FDG PET/CT.

Authors:  Minyoung Oh; Sora Baek; Sang-Oh Lee; Eunsil Yu; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2012-03-27

3.  A case of acute q Fever with severe acute cholestatic hepatitis.

Authors:  Hyun Cheul Choi; Sang Hyub Lee; Junghee Kim; Sung Han Kim; Jin-Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Haeryoung Kim
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

4.  Q Fever in Southern California: a Case Series of 20 Patients from a VA Medical Center.

Authors:  Christine M Akamine; Mario L Perez; Jea Hyun Lee; Michael B Ing
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

5.  Clinicopathologic features of q Fever patients with acute hepatitis.

Authors:  Miji Lee; Jae Jeong Jang; Yang Soo Kim; Sang-Oh Lee; Sang-Ho Choi; Sung-Han Kim; Eunsil Yu
Journal:  Korean J Pathol       Date:  2012-02-23

6.  Q Fever in Southern California: 11 Patient Cases from a Community-Based Organization.

Authors:  Andre K Johnson; Falguni R Patel; Jon G Persichino
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

7.  Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.

Authors:  Marissa S Fullerton; Punsiri M Colonne; Amanda L Dragan; Katelynn R Brann; Richard C Kurten; Daniel E Voth
Journal:  mSphere       Date:  2021-07-07       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.